Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge

Bibhu D. Mohanty, Sudipta Mohanty, Yasin Hussain, Chandrasekhar Padmaraju, Sameer Aggarwal, Rebekah Gospin, Anthony F. Yu

Research output: Contribution to journalReview articlepeer-review

Abstract

Acute coronary syndrome (ACS) coinciding with active malignancy presents a unique clinical challenge given intersecting pathophysiology and treatment-related effects. There is little established clinical guidance on management strategies, rendering most treatment approaches anecdotal. We present a case highlighting the complexity of managing a patient being treated for malignancy who concurrently suffers from ACS. We then review the literature on co-management of ACS and malignancy, including reports of specific cancer therapies associated with ACS, unique features of clinical presentation and optimal use of dual antiplatelet therapy to minimize risks of bleeding and thrombosis. We also describe gaps in current literature, challenges in systematically studying the clinical intersection of these disease processes and propose alternative methodologies for further research.

Original languageEnglish (US)
Pages (from-to)247-257
Number of pages11
JournalFuture Cardiology
Volume13
Issue number3
DOIs
StatePublished - May 2017

Keywords

  • acute coronary syndrome
  • cancer
  • cardio-oncology
  • chemotherapy
  • ischemic heart disease

ASJC Scopus subject areas

  • Molecular Medicine
  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Management of ischemic coronary disease in patients receiving chemotherapy: An uncharted clinical challenge'. Together they form a unique fingerprint.

Cite this